Thats what this forum is all about, discussing different views in a polite manner. Not all of us will agree on all the issues. I'm not trying to pick sides and I respect your opinions and in depth knowledge of PTSC as well as Lamberts and Milestones. You and I will agree to disagree on this subject for now. If I see very little appreciable gains over the next two years in regards to the PDSG products revenue levels as compared to salaries and compensation for the BOD and the executives then I will gravitate towards your way of thinking. But IMO they deserve more time to make it happen. The licensing of the MMP through TPL has provided the potential for a resurection of PTSC from the dead.

Look at your chart and remember the levels we were at before the run up? Looking back I think we can conclude that the valuation by the market was over inflated with respect to the effects of the USPTO review on licensing revenues. The SP is where it should be imo based on the problems facing the MMP and the infancy of PDSG. And I'm just not sure we can blame the BOD members for this at this time when they made the decisions that got the company out of debt and enabled PTSC to build into a real company again from the shell it once was. I don't know the board members, so I can't judge what wisdom they bring to the table.

All the best,

Steve